GS

Gudemaranahalli Sundara Ashish

Active Director Director DIN 10114244
DIN 10114244 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Gudemaranahalli Sundara Ashish

Data last updated:

Gudemaranahalli Sundara Ashish is a Director at Celixia Life Sciences Private Limited (since 2023). The company operates in Paper.

DIN 10114244
Primary Designation Director
Industry Paper
First Appointment 12 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Apr 20232023Active

Board colleagues of Gudemaranahalli Sundara Ashish

NameDINCompanyDesignation
Cheruku Sri Laxmi10114243Celixia Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Celixia Life Sciences Private Limited
Premium access

Shareholding and investment profile for Gudemaranahalli Sundara Ashish

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gudemaranahalli Sundara Ashish

Gudemaranahalli Sundara Ashish currently holds 1 directorship: Celixia Life Sciences Private Limited (Director, since 12 Apr 2023).

Gudemaranahalli Sundara Ashish was first appointed on 12 Apr 2023 as Director at Celixia Life Sciences Private Limited.

The current boards of Gudemaranahalli Sundara Ashish's companies include Cheruku Sri Laxmi (Celixia Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available